J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.BO)
INR 1941.8
(4.63%)
INR 1941.8
(4.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 14.28 Billion INR | 29.78% |
| 2022 | 5.84 Billion INR | 26.93% |
| 2021 | 4.6 Billion INR | 1.06% |
| 2020 | 4.55 Billion INR | 56.63% |
| 2019 | 2.9 Billion INR | 30.79% |
| 2018 | 2.22 Billion INR | 50.66% |
| 2017 | 1.47 Billion INR | -35.8% |
| 2016 | 2.29 Billion INR | 8.35% |
| 2015 | 2.12 Billion INR | 45.82% |
| 2014 | 1.45 Billion INR | 66.45% |
| 2013 | 874.45 Million INR | -15.57% |
| 2012 | 1.03 Billion INR | -22.16% |
| 2011 | 1.33 Billion INR | -26.93% |
| 2010 | 1.82 Billion INR | 28.92% |
| 2009 | 1.41 Billion INR | 281.04% |
| 2008 | 370.66 Million INR | -15.16% |
| 2007 | 436.9 Million INR | -38.6% |
| 2006 | 711.56 Million INR | -14.21% |
| 2005 | 829.44 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.39 Billion INR | 52.24% |
| 2023 Q2 | 2.11 Billion INR | 5.3% |
| 2023 FY | 7.58 Billion INR | 29.78% |
| 2023 Q4 | 1.57 Billion INR | -16.77% |
| 2023 Q3 | 1.89 Billion INR | -10.54% |
| 2023 Q1 | 2 Billion INR | 52.25% |
| 2022 Q4 | 1.31 Billion INR | -9.93% |
| 2022 Q1 | 1.46 Billion INR | 42.66% |
| 2022 FY | 5.84 Billion INR | 26.93% |
| 2022 Q2 | 1.56 Billion INR | 6.66% |
| 2022 Q3 | 1.46 Billion INR | -6.44% |
| 2021 Q1 | 1.45 Billion INR | 35.83% |
| 2021 Q4 | 1.02 Billion INR | -7.49% |
| 2021 FY | 4.6 Billion INR | 1.06% |
| 2021 Q3 | 1.11 Billion INR | 0.12% |
| 2021 Q2 | 1.11 Billion INR | -23.88% |
| 2020 Q1 | 1.6 Billion INR | 138.56% |
| 2020 FY | 4.55 Billion INR | 56.63% |
| 2020 Q4 | 1.07 Billion INR | -48.77% |
| 2020 Q2 | 1.01 Billion INR | -37.17% |
| 2020 Q3 | 2.09 Billion INR | 107.38% |
| 2019 Q3 | 892.27 Million INR | -12.85% |
| 2019 Q4 | 674.1 Million INR | -24.45% |
| 2019 Q2 | 1.02 Billion INR | 10.34% |
| 2019 Q1 | 927.89 Million INR | 34.84% |
| 2019 FY | 2.9 Billion INR | 30.79% |
| 2018 Q1 | 675.48 Million INR | 0.0% |
| 2018 Q3 | 791.37 Million INR | 5.01% |
| 2018 FY | 2.22 Billion INR | 50.66% |
| 2018 Q4 | 688.14 Million INR | -13.04% |
| 2018 Q2 | 753.63 Million INR | 11.57% |
| 2017 Q1 | 260.11 Million INR | -45.21% |
| 2017 FY | 1.47 Billion INR | -35.8% |
| 2016 FY | 2.29 Billion INR | 8.35% |
| 2016 Q4 | 474.73 Million INR | 0.0% |
| 2015 Q4 | 632.83 Million INR | 0.0% |
| 2015 FY | 2.12 Billion INR | 45.82% |
| 2014 FY | 1.45 Billion INR | 66.45% |
| 2013 Q1 | 328.88 Million INR | 0.0% |
| 2013 FY | 874.45 Million INR | -15.57% |
| 2012 FY | 1.03 Billion INR | -22.16% |
| 2012 Q1 | 139.68 Million INR | 0.0% |
| 2011 FY | 1.33 Billion INR | -26.93% |
| 2010 FY | 1.82 Billion INR | 28.92% |
| 2009 FY | 1.41 Billion INR | 281.04% |
| 2008 FY | 370.66 Million INR | -15.16% |
| 2007 FY | 436.9 Million INR | -38.6% |
| 2006 FY | 711.56 Million INR | -14.21% |
| 2005 FY | 829.44 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 19.67 Billion INR | 27.415% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -3021.626% |
| Sigachi Industries Limited | 1.47 Billion INR | -869.051% |
| Bal Pharma Limited | 233.9 Million INR | -6006.14% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -223.1% |
| Medico Remedies Limited | 100.3 Million INR | -14140.091% |
| Lasa Supergenerics Limited | -458 Million INR | 3218.484% |
| Venus Remedies Limited | 534.65 Million INR | -2571.427% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 447.088% |
| Alpa Laboratories Limited | 184.49 Million INR | -7641.487% |
| Nectar Lifesciences Limited | 923.8 Million INR | -1446.083% |
| Shilpa Medicare Limited | 1.36 Billion INR | -945.386% |
| Aarti Drugs Limited | 7.14 Billion INR | -99.795% |
| Lupin Limited | 28.04 Billion INR | 49.071% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 66.157% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 66.867% |
| Windlas Biotech Limited | 1.29 Billion INR | -999.617% |
| Suven Life Sciences Limited | -1.22 Billion INR | 1265.162% |
| Eris Lifesciences Limited | 5.18 Billion INR | -175.638% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 470.703% |
| Ipca Laboratories Limited | 7.98 Billion INR | -78.969% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -1060.26% |
| Achyut Healthcare Limited | 4.43 Million INR | -321729.901% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 86.307% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| RPG Life Sciences Limited | 2.29 Billion INR | -523.078% |
| Mankind Pharma Limited | 21.51 Billion INR | 33.624% |
| Laurus Labs Limited | 3.94 Billion INR | -261.718% |
| Piramal Pharma Limited | 4.55 Billion INR | -213.433% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -5630.292% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 43.625% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -148.047% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -119.655% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -2179.778% |
| Wanbury Limited | 569.71 Million INR | -2407.005% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -209.981% |
| Wockhardt Limited | -670 Million INR | 2231.763% |
| Themis Medicare Limited | 392.58 Million INR | -3538.108% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -2710.858% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -175.252% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -59.066% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 78.912% |
| Divi's Laboratories Limited | 33.08 Billion INR | 56.823% |
| NATCO Pharma Limited | 25.96 Billion INR | 44.986% |
| Gufic Biosciences Limited | 1.32 Billion INR | -973.968% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -794.465% |
| Ind-Swift Limited | 1.22 Billion INR | -1065.027% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -412.664% |
| FDC Limited | 2.98 Billion INR | -378.292% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 9499.245% |
| Granules India Limited | 6.81 Billion INR | -109.526% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Alkem Laboratories Limited | 19.46 Billion INR | 26.611% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -731.605% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -157395.683% |
| Brooks Laboratories Limited | 14.44 Million INR | -98811.434% |
| Megasoft Limited | -121.1 Million INR | 11893.839% |
| ZIM Laboratories Limited | 253.82 Million INR | -5526.942% |
| Strides Pharma Science Limited | 5.22 Billion INR | -173.313% |
| Neuland Laboratories Limited | 5.31 Billion INR | -168.57% |
| Morepen Laboratories Limited | 4.17 Billion INR | -242.199% |
| Hikal Limited | 32.11 Million INR | -44380.881% |
| Indoco Remedies Limited | 1.29 Billion INR | -1005.011% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -356.595% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -6765.086% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -51916.939% |
| Hester Biosciences Limited | 364.81 Million INR | -3815.137% |